Drugs with high-affinity for pre- and postsynaptic D2 and 5-HT1A receptors are best described as which class?

Drugs with high-affinity for pre- and postsynaptic D2 and 5-HT1A receptors are best described as which class?

• A. Full agonists
• B. Inverse agonists
• C. Partial agonists
• D. Antagonists

Answer: (C)

Partial agonists produce a submaximal response even when they occupy all the receptors, giving them a stabilizing effect on signaling. Drugs with high affinity for both presynaptic D2 autoreceptors and postsynaptic D2 receptors, as well as for 5-HT1A receptors, can modestly activate these receptors rather than fully driving them or fully blocking them. This means they can dampen excessive dopamine activity when it’s high (through autoreceptor engagement) and provide some receptor stimulation when dopamine is low, leading to a balanced dopaminergic tone. At the same time, their action at 5-HT1A receptors modulates serotonin signaling, contributing to antipsychotic and mood-related benefits without the extremes of a full agonist. In contrast, a full agonist would drive receptor activity to the maximum, an antagonist would block signaling entirely, and an inverse agonist would reduce baseline receptor activity below normal. Hence, drugs with this receptor profile are best described as partial agonists.

Partial agonists produce a submaximal response even when they occupy all the receptors, giving them a stabilizing effect on signaling. Drugs with high affinity for both presynaptic D2 autoreceptors and postsynaptic D2 receptors, as well as for 5-HT1A receptors, can modestly activate these receptors rather than fully driving them or fully blocking them. This means they can dampen excessive dopamine activity when it’s high (through autoreceptor engagement) and provide some receptor stimulation when dopamine is low, leading to a balanced dopaminergic tone. At the same time, their action at 5-HT1A receptors modulates serotonin signaling, contributing to antipsychotic and mood-related benefits without the extremes of a full agonist. In contrast, a full agonist would drive receptor activity to the maximum, an antagonist would block signaling entirely, and an inverse agonist would reduce baseline receptor activity below normal. Hence, drugs with this receptor profile are best described as partial agonists.